Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 3 EP applications Olaf Wrobel has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 15, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12748426

PHARMACEUTICAL AEROSOL PRODUCT FOR ADMINISTRATION BY ORAL OR NASAL INHALATION

IPC classification:
A61K 9/00, A61K 9/12, A61K 31/57, A61K 47/10
Applicant:
AstraZeneca AB
Applicant:
Takeda GmbH
Agent:
Tracy Anne Burns, AstraZeneca PLC
Agent:
Olaf Wrobel, Takeda GmbH
Status:
GRANT OF PATENT INTENDED
EP15707836

PYRAZINES MODULATORS OF GPR6

IPC classification:
A61K 31/497, A61K 31/5377, A61P 25/00, C07D 241/26, C07D 241/28, C07D 401/04
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Almut Susanne Elend, Venner Shipley LLP
Agent:
Olaf Wrobel, Takeda GmbH
Status:
EXAMINATION REQUESTED
EP15707835

PYRIDOPYRAZINES MODULATORS OF GPR6

IPC classification:
A61K 31/4985, A61P 25/00, C07D 471/04
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Almut Susanne Elend, Venner Shipley LLP
Agent:
Olaf Wrobel, Takeda GmbH
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature